Company:  ENZO BIOCHEM INC (ENZ)
Form Type:  PREC14A
Filing Date:  11/25/2015 
CIK:  0000316253 
Address:  60 EXECUTIVE BLVD 
City, State, Zip:  FARMINGDALE, New York 11735 
Telephone:  (516) 755-5500 
Fiscal Year:  07/31 
Last Trade
Last Trade: 
$2.53  
Change: 
0.00 (0.00%)  
Trade Time: 
Aug 05  
Market Cap: 
$123.26M
Trade ENZ now with 

© 2022  
Description of Business
Enzo Biochem, Inc. (the "Company" "we", "our" or "Enzo") is an integrated diagnostics, clinical lab, and life sciences company focused on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable our customers to meet their clinical needs. Through a connection with the market, we provide advanced biotechnology solutions to the global community as affordable and flexible quality products and services. We develop, manufacture and sell our proprietary technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's structure and business strategy represent the culmination of years of extensive planning and work. The Company has the unique ability to offer low cost, high performance products and services for diagnostic testing, which ideally positions us to capitalize on the reimbursement pressures facing diagnostic labs.
Register and access this filing in:     
  FORM PREC14A
    THIS PROXY STATEMENT AND PROXY CARD ARE
    NOTICE OF 2015 ANNUAL MEETING OF SHAREHOLDERS
    PROXY STATEMENT
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
    PROPOSAL 1
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
      NAME AND TITLE
    AUDIT COMMITTEE REPORT
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    COMPENSATION OF DIRECTORS
    COMPENSATION OF EXECUTIVE OFFICERS
      COMPENSATION TABLE
      OPTIONS
      NAME AND TITLE
    COMPENSATION COMMITTEE REPORT
    COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
    PROPOSAL 2
    PROPOSAL 3
    OTHER MATTERS
    ANNUAL REPORT
    SHAREHOLDER PROPOSALS
      NAME AND TITLE